APXI Stock Forecast 2025-2026
Distance to APXI Price Targets
APXI Price Momentum
🤔 Considering APx Acquisition (APXI)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Latest APXI Stock Price Targets & Analyst Predictions
APXI has shown a year-to-date change of 0.0% and a 1-year change of 4.5%, reflecting upward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for APXI. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
APXI Analyst Ratings
APXI Price Target Range
Latest APXI Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for APXI.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
APx Acquisition Corp. I (APXI) Competitors
The following stocks are similar to APx Acquisition based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
APx Acquisition Corp. I (APXI) Financial Data
APx Acquisition Corp. I has a market capitalization of $117.93M with a P/E ratio of 108.2x. The company generates $0 in trailing twelve-month revenue with a 0.0% profit margin.
Revenue growth is N/A quarter-over-quarter, while maintaining an operating margin of 0.0% and return on equity of +7.0%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
APx Acquisition Corp. I (APXI) Business Model
About APx Acquisition Corp. I
Engages in business combinations and acquisitions.
The company operates as a special purpose acquisition company (SPAC), intending to identify and merge with a target business to generate value for investors. It makes money by raising capital through an initial public offering (IPO) and subsequently executing business combinations.
Incorporated in 2021 and headquartered in Nashville, Tennessee, this company is focused on strategic partnerships and growth opportunities in various industries.
APx Acquisition Corp. I (APXI) Latest News & Analysis
APX Acquisition Corp. I (NASDAQ: APXI) has been notified by Nasdaq of non-compliance with listing criteria due to its outstanding warrants' market value falling below $1 million.
APX Acquisition Corp. I's non-compliance with Nasdaq listing criteria due to low market value of warrants raises concerns about its financial health and could lead to delisting, impacting stock value.
APX Acquisition Corp. I (NASDAQ: APXI) received a deficiency letter from Nasdaq on May 30, 2024, regarding its compliance with listing qualifications.
APX Acquisition Corp. I's receipt of a deficiency letter from Nasdaq raises concerns about its compliance with listing standards, potentially impacting its stock price and investor confidence.
APx Acquisition Corp. I (NASDAQ: APXI) has signed a Business Combination Agreement with OmnigenicsAI Corp and MultiplAI Health Ltd, aiming to make OmnigenicsAI a publicly listed company.
The merger of APx Acquisition Corp. with OmnigenicsAI may create investment opportunities in the growing precision medicine sector, potentially impacting stock performance and market sentiment.
APX Acquisition Corp. I (NASDAQ: APXI) received a deficiency letter from Nasdaq on December 21, 2023, indicating potential non-compliance with listing requirements.
APX Acquisition Corp. I's deficiency letter from Nasdaq raises concerns about its compliance, potentially affecting stock price and investor confidence.
APX Acquisition Corp. I (NASDAQ: APXI) has signed a non-binding LOI for a business combination with a precision medicine company focused on genomic diagnostics and wellness services, aiming for a public listing.
The announcement of a potential merger with a precision medicine company could enhance APXI's growth prospects, attract investor interest, and lead to increased stock volatility.
APx Acquisition Corp. I Receives NASDAQ Notification of Non-Compliance With Listing Rules
2 years agoAPx Acquisition Corp. I (NASDAQ: APXI) received a notice from NASDAQ regarding non-compliance with listing qualifications as of August 23, 2022.
Non-compliance with NASDAQ listing rules raises concerns about APx's financial health and ability to complete its merger plans, potentially affecting stock value and investor confidence.
Frequently Asked Questions About APXI Stock
What is APx Acquisition Corp. I's (APXI) stock forecast for 2025?
Analyst forecasts for APx Acquisition Corp. I (APXI) are not currently available. The stock is trading at $11.90.
Is APXI stock a good investment in 2025?
Analyst ratings for APXI are not currently available. The stock is currently trading at $11.90. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for APXI stock?
Price predictions from Wall Street analysts for APXI are not currently available. The stock is trading at $11.90.
What is APx Acquisition Corp. I's business model?
The company operates as a special purpose acquisition company (SPAC), intending to identify and merge with a target business to generate value for investors. It makes money by raising capital through an initial public offering (IPO) and subsequently executing business combinations.
What is the highest forecasted price for APXI APx Acquisition Corp. I?
Price targets from Wall Street analysts for APXI are not currently available. The stock is trading at $11.90.
What is the lowest forecasted price for APXI APx Acquisition Corp. I?
Price targets from Wall Street analysts for APXI are not currently available. The stock is trading at $11.90.
What is the overall APXI consensus from analysts for APx Acquisition Corp. I?
Analyst ratings for APXI are not currently available. The stock is trading at $11.90.
How accurate are APXI stock price projections?
Stock price projections, including those for APx Acquisition Corp. I, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
